Lineage Cell Therapeutics (LCTX) Institutional Ownership $1.20 +0.18 (+17.65%) Closing price 08/15/2025 04:10 PM EasternExtended Trading$1.22 +0.02 (+1.25%) As of 08/15/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)CurrentInstitutional OwnershipPercentage62.47%Number ofInstitutional Buyers(last 12 months)44TotalInstitutional Inflows(last 12 months)$13.17MNumber ofInstitutional Sellers(last 12 months)11TotalInstitutional Outflows(last 12 months)$2.77M Get LCTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Lineage Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LCTX Institutional Buying and Selling by Quarter Lineage Cell Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025Raffles Associates LP5,392,088$4.89M5.1%-4.4%2.361% 8/15/2025 Hudson Bay Capital Management LP48,330$44K0.0%N/A0.021% 8/15/2025 Bridgeway Capital Management LLC150,000$136K0.0%-10.7%0.066% 8/15/2025 Brevan Howard Capital Management LP308,877$281K0.0%N/A0.135% 8/15/2025 Bank of America Corp DE103,312$94K0.0%-35.8%0.045% 8/14/2025 Raymond James Financial Inc.69,380$63K0.0%+136.2%0.030% 8/14/2025 Qube Research & Technologies Ltd39,036$35K0.0%N/A0.017% 8/14/2025 WINTON GROUP Ltd76,061$69K0.0%N/A0.033% 8/13/2025 Jump Financial LLC31,060$28K0.0%N/A0.014% 8/12/2025 XTX Topco Ltd94,054$85K0.0%+117.8%0.041% Get the Latest News and Ratings for LCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/12/2025 Catalyst Funds Management Pty Ltd83,100$75K0.0%N/A0.036% 8/8/2025 Geode Capital Management LLC2,431,619$2.21M0.0%-45.8%1.065% 8/4/2025 Integrity Alliance LLC.35,000$32K0.0%+75.0%0.015% 8/1/2025 Y Intercept Hong Kong Ltd405,043$368K0.0%N/A0.177% 7/31/2025 Ground Swell Capital LLC104,511$95K0.2%N/A0.046% 7/29/2025 Cannon Global Investment Management LLC33,000$30K0.1%N/A0.014% 7/25/2025 Defender Capital LLC.6,785,177$6.16M2.1%+7.5%2.971% 7/16/2025 ORG Partners LLC59,200$53K0.0%-48.7%0.026% 7/14/2025 Kapitalo Investimentos Ltda27,130$25K0.0%N/A0.012% 6/27/2025 Goldman Sachs Group Inc.350,103$158K0.0%-9.1%0.153% 5/29/2025 Rhumbline Advisers201,447$91K0.0%+9.9%0.091% 5/19/2025 Jane Street Group LLC68,068$31K0.0%-74.1%0.031% 5/16/2025 Goldman Sachs Group Inc.350,103$158K0.0%-9.1%0.159% 5/16/2025 Broadwood Capital Inc.49,560,992$22.38M1.8%+18.9%22.485% 5/15/2025 Royal Bank of Canada528,656$237K0.0%+1,578.9%0.240% 5/15/2025 MAI Capital Management64,391$29K0.0%-90.2%0.029% 5/14/2025 Comerica Bank3,000,000$1.36M0.0%+275.0%1.361% 5/13/2025 Cookson Peirce & Co. Inc.250,000$113K0.0%N/A0.113% 5/12/2025 Nuveen LLC515,445$233K0.0%N/A0.234% 5/12/2025 Red Crane Wealth Management LLC495,996$224K0.2%+45.8%0.225% 5/9/2025 Charles Schwab Investment Management Inc.503,193$227K0.0%+20.9%0.228% 4/28/2025 Defender Capital LLC.6,310,873$2.84M1.1%+5.8%2.863% 4/21/2025 ORG Partners LLC115,400$47K0.0%N/A0.052% 2/17/2025 Squarepoint Ops LLC92,001$46K0.0%N/A0.042% 2/17/2025 Two Sigma Advisers LP86,964$44K0.0%+312.2%0.039% 2/17/2025 Two Sigma Investments LP301,544$152K0.0%N/A0.137% 2/17/2025 Jacobs Levy Equity Management Inc.1,033,763$519K0.0%N/A0.469% 2/17/2025 Deutsche Bank AG174,702$87K0.0%+196.0%0.079% 2/17/2025 DAFNA Capital Management LLC2,511,374$1.26M0.3%+85.9%1.139% 2/17/2025 Bridgeway Capital Management LLC417,900$210K0.0%-44.8%0.190% Turn $1K into $50K with This DeFi Gem (Ad)The "altcoin massacre" that's about to make millionaires The question isn't IF altcoins will explode higher… It's WHETHER you'll be positioned in the right ones when they do.Get positioned now by claiming your discount on Crypto Revolution.2/17/2025 Alyeska Investment Group L.P.3,947,369$1.98M0.0%N/A1.791% 2/14/2025 Jane Street Group LLC262,866$132K0.0%+119.2%0.119% 2/14/2025Raffles Associates LP5,492,088$2.76M3.0%+21.8%2.492% 2/14/2025 Comerica Bank800,000$402K0.0%+220.0%0.363% 2/13/2025 Barclays PLC234,069$118K0.0%+10.8%0.106% 2/13/2025 Renaissance Technologies LLC2,283,072$1.15M0.0%+1,058.3%1.036% 2/13/2025 Wells Fargo & Company MN94,894$48K0.0%+33.0%0.043% 2/12/2025 JPMorgan Chase & Co.946,399$476K0.0%+39.8%0.429% 2/7/2025 HighTower Advisors LLC57,706$29K0.0%+49.5%0.026% 2/5/2025 Fort Sheridan Advisors LLC55,177$28K0.0%+71.5%0.025% 2/5/2025 Red Crane Wealth Management LLC340,236$171K0.2%N/A0.154% 1/31/2025 Atria Wealth Solutions Inc.57,423$29K0.0%N/A0.026% 1/23/2025 Defender Capital LLC.5,963,348$3.00M1.1%+19.2%2.705% 1/17/2025 SG Americas Securities LLC68,973$35K0.0%+35.5%0.031% 12/26/2024 JPMorgan Chase & Co.677,162$613K0.0%+13.9%0.307% 11/19/2024 Barclays PLC211,300$192K0.0%+311.3%0.096% 11/16/2024 Geode Capital Management LLC3,679,280$3.33M0.0%+2.3%1.948% 11/15/2024 Barclays PLC211,300$192K0.0%+311.3%0.112% 11/15/2024 Jane Street Group LLC119,901$109K0.0%-50.6%0.063% 11/15/2024 State Street Corp2,608,352$2.36M0.0%+1.8%1.381% 11/15/2024 HighTower Advisors LLC38,606$35K0.0%-30.7%0.020% 11/14/2024Raffles Associates LP4,507,781$4.08M4.2%+3.4%2.387% 11/8/2024 Connor Clark & Lunn Investment Management Ltd.191,436$173K0.0%-7.9%0.101% 11/7/2024 MAI Capital Management1,674,679$1.52M0.0%+2.2%0.887% 11/5/2024 GSA Capital Partners LLP93,032$84K0.0%N/A0.049% 10/21/2024 Defender Capital LLC.5,002,198$4.53M1.5%+0.6%2.649% 10/3/2024 SG Americas Securities LLC50,920$46K0.0%N/A0.027% 8/27/2024 Logos Global Management LP4,700,000$4.69M0.4%-24.8%2.489% 8/14/2024Raffles Associates LP4,357,781$4.35M4.9%+35.8%2.308% 8/14/2024 Logos Global Management LP4,700,000$4.69M0.4%-24.8%2.489% 8/12/2024 XTX Topco Ltd61,515$61K0.0%N/A0.033% 8/9/2024 Renaissance Technologies LLC583,622$582K0.0%+10.0%0.309% 8/1/2024 Rhumbline Advisers132,491$132K0.0%+15.1%0.070% 7/26/2024 Bank of New York Mellon Corp435,958$435K0.0%+35.7%0.231% 5/17/2024 Comerica Bank250,295$370K0.0%+84,745.8%0.133% 5/15/2024 Price T Rowe Associates Inc. MD161,314$239K0.0%+77.5%0.085% 5/10/2024 Vanguard Group Inc.8,373,771$12.39M0.0%-0.1%4.435% 4/16/2024 Fifth Third Wealth Advisors LLC20,000$30K0.0%N/A0.011% 2/13/2024 DCF Advisers LLC94,751$103K0.1%+14.5%0.054% 1/23/2024 Defender Capital LLC.4,969,675$5.42M1.9%-4.1%2.840% 1/12/2024 SG Americas Securities LLC30,889$34K0.0%+61.6%0.018% 12/6/2023 Citigroup Inc.133,051$157K0.0%-16.2%0.076% 11/15/2023 Laurion Capital Management LP1,136,471$1.34M0.0%-42.2%0.649% 11/13/2023 Connor Clark & Lunn Investment Management Ltd.182,561$215K0.0%-27.9%0.104% 11/13/2023 Rathbones Group PLC35,000$41K0.0%N/A0.020% 10/23/2023 Defender Capital LLC.5,184,510$6.12M2.2%+1.5%2.963% 9/21/2023 Barclays PLC25,905$36K0.0%+87.3%0.015% 8/15/2023Raffles Associates LP1,597,739$2.25M3.0%+4.0%0.913% 8/4/2023 American International Group Inc.62,114$88K0.0%N/A0.036% 8/2/2023 MAI Capital Management951,578$1.34M0.0%+123.8%0.545% Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here8/1/2023 Fort Sheridan Advisors LLC83,931$118K0.0%+13.5%0.049% 7/18/2023 Defender Capital LLC.5,109,710$7.20M2.5%-0.5%3.003% 7/10/2023 Trust Co. of Toledo NA OH35,394$50K0.0%+41.6%0.021% 6/1/2023 Prelude Capital Management LLC16,688$25K0.0%N/A0.010% 5/15/2023 Fort Sheridan Advisors LLC73,931$111K0.0%-11.9%0.043% 5/12/2023 Long Focus Capital Management LLC175,000$262K0.0%-18.6%0.103% 5/11/2023 PFG Investments LLC20,200$30K0.0%N/A0.012% 5/10/2023 Summit X LLC21,925$33K0.0%-26.7%0.013% 5/10/2023 MAI Capital Management425,115$638K0.0%-6.9%0.250% 5/10/2023 Connor Clark & Lunn Investment Management Ltd.241,022$362K0.0%-8.0%0.142% (Data available from 1/1/2016 forward) LCTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LCTX shares? During the previous two years, 57 institutional investors and hedge funds held shares of Lineage Cell Therapeutics. The most heavily invested institutionals were Broadwood Capital Inc. ($22.38M), Vanguard Group Inc. ($12.39M), Defender Capital LLC. ($6.16M), Raffles Associates LP ($4.89M), Logos Global Management LP ($4.69M), State Street Corp ($2.36M), and Geode Capital Management LLC ($2.21M).Learn more on Lineage Cell Therapeutics' institutional investors. What percentage of Lineage Cell Therapeutics' stock is owned by institutional investors? 62.47% of Lineage Cell Therapeutics' stock is owned by institutional investors. Learn more on LCTX's institutional investor holdings. Which institutional investors have been buying Lineage Cell Therapeutics' stock? Of the 49 institutional investors that purchased Lineage Cell Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Broadwood Capital Inc. ($7.89M), Alyeska Investment Group L.P. ($3.95M), Comerica Bank ($3M), Raffles Associates LP ($2.28M), Renaissance Technologies LLC ($2.14M), Defender Capital LLC. ($1.89M), and DAFNA Capital Management LLC ($1.16M). How much institutional buying is happening at Lineage Cell Therapeutics? Institutional investors have bought a total of 26,922,603 shares in the last 24 months. This purchase volume represents approximately $13.17M in transactions. Which of Lineage Cell Therapeutics' major shareholders have been selling company stock? Of the 11 institutional investors that sold Lineage Cell Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Geode Capital Management LLC ($2.05M), Logos Global Management LP ($1.55M), MAI Capital Management ($593.29K), Bridgeway Capital Management LLC ($356.77K), Jane Street Group LLC ($317.85K), Raffles Associates LP ($250K), and Goldman Sachs Group Inc. ($69.93K). How much institutional selling is happening at Lineage Cell Therapeutics? Institutional investors have sold a total of 5,339,053 shares in the last 24 months. This volume of shares sold represents approximately $2.77M in transactions. Related Companies Enliven Therapeutics Major Shareholders Upstream Bio Major Shareholders Anavex Life Sciences Major Shareholders Sionna Therapeutics Major Shareholders Zymeworks Major Shareholders Akebia Therapeutics Major Shareholders Trevi Therapeutics Major Shareholders Mineralys Therapeutics Major Shareholders Urogen Pharma Major Shareholders Immunome Major Shareholders This page (NYSEAMERICAN:LCTX) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lineage Cell Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lineage Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access